World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
41884
World Ranking
13875
National Ranking
7043

Laurie E. Gaspar publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Laurie E. Gaspar sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 375 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Laurie E. Gaspar D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Laurie E. Gaspar sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Laurie E. Gaspar is affiliated with the University of Colorado Denver in the United States. Their research primarily focuses on medical fields, with a strong emphasis on pulmonary and respiratory medicine, oncology, epidemiology, radiation, and radiology, nuclear medicine, and imaging.

The key research topics in Gaspar's body of work include:

  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Brain Metastases and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Advanced Radiotherapy Techniques
  • Glioma Diagnosis and Treatment

Gaspar has published extensively in several scientific venues, with frequent contributions to:

  • Journal of Clinical Oncology (9 publications)
  • International Journal of Radiation Oncology*Biology*Physics (6 publications)
  • Neuro-Oncology (2 publications)
  • Radiotherapy and Oncology (1 publication)
  • Lung Cancer (1 publication)

Among notable publications are:

  • Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline, 2021, Journal of Clinical Oncology
  • Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update, 2020, Journal of Clinical Oncology
  • Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient, 2020, Journal of Clinical Oncology
  • Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update, 2021, Journal of Clinical Oncology
  • Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today, 2020, International Journal of Radiation Oncology*Biology*Physics

Gaspar frequently collaborates with several researchers, including:

  • Paul D. Brown
  • Gregory A. Masters
  • Minesh P. Mehta
  • Junheng Gao
  • John V. Heymach

The scientist's work spans a wide array of clinical and research-oriented areas in medicine, particularly emphasizing the development of treatments and prognostic assessments for lung cancer and brain metastases. Their research includes updated guidelines and summary reports that contribute to the understanding and clinical management of these conditions.

Best Publications

  • Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

    Laurie Gaspar;Charles Scott;Marvin Rotman;Sucha Asbell

  • Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

    David W Andrews;Charles B Scott;Paul W Sperduto;Adam E Flanders

  • Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu

  • Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

    Daniel R. Gomez;Chad Tang;Jianjun Zhang;George R. Blumenschein

  • Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    Daniel R Gomez;George R Blumenschein;J Jack Lee;Mike Hernandez

  • A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database

    Paul W. Sperduto;Brian Berkey;Laurie E. Gaspar;Minesh Mehta

  • Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

    Paul W. Sperduto;Samuel T. Chao;Penny K. Sneed;Xianghua Luo

  • Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

    Kyle E. Rusthoven;Brian D. Kavanagh;Stuart H. Burri;Changhu Chen

  • Response assessment criteria for brain metastases: proposal from the RANO group

    Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani

  • A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis

    Arlan H. Mintz;John Kestle;Michel P. Rathbone;Laurie Gaspar

  • Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023

    Karen Kelly;Kari Chansky;Laurie E. Gaspar;Kathy S. Albain

  • Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    Andrew J. Weickhardt;Benjamin Scheier;Joseph Malachy Burke;Gregory Gan

  • Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

    May N. Tsao;Dirk Rades;Andrew Wirth;Simon S. Lo

  • Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.

    Laurie E. Gaspar;Charles Scott;Kevin Murray;Walter Curran

  • Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial

    Christina A. Meyers;Jennifer A. Smith;Andrea Bezjak;Minesh P. Mehta

  • Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

    Paul W. Sperduto;T. Jonathan Yang;Kathryn Beal;Hubert Pan

  • The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

    Mark E. Linskey;David W. Andrews;Anthony L. Asher;Stuart H. Burri

  • Patterns of Surgical Care of Lung Cancer Patients

    Alex G. Little;Valerie W. Rusch;James A. Bonner;Laurie E. Gaspar

  • Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504

    David R. Gandara;Kari Chansky;Kathy S. Albain;Bryan R. Leigh

  • A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.

    Tracey E. Schefter;Brian D. Kavanagh;Robert D. Timmerman;Higinia R. Cardenes

Frequent Co-Authors

Minesh P. Mehta
Minesh P. Mehta University of Maryland, Baltimore
Paul D. Brown
Paul D. Brown Mayo Clinic
D. Ross Camidge
D. Ross Camidge University of Colorado Anschutz Medical Campus
David R. Gandara
David R. Gandara University of California, Davis
John H. Suh
John H. Suh Cleveland Clinic
Robert Timmerman
Robert Timmerman The University of Texas Southwestern Medical Center
Walter J. Curran
Walter J. Curran Emory University
David W. Andrews
David W. Andrews Sunnybrook Health Science Centre
Penny K. Sneed
Penny K. Sneed University of California, San Francisco
Kathy S. Albain
Kathy S. Albain Loyola University Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their career options in healthcare, there are numerous online degree pathways to consider. Many students pursue advanced qualifications such as becoming a nurse practitioner, which offers greater responsibilities and earning potential. If cost is a concern, there are several cheap np programs that provide flexible study options while keeping tuition affordable.

For registered nurses aiming to take on leadership or specialized roles, earning a Master of Science in Nursing is a smart step. Numerous cheapest online msn programs in the U.S. allow busy professionals to advance their career without compromising their work or family commitments.

If you are focused on education, research, or policy, pursuing a doctorate may be the right move. Accredited phd nursing programs can open doors to academic and leadership positions.

Additionally, RNs looking to complete their bachelor’s degree can find a range of cheapest bsn programs. These online pathways make it easier to stay competitive and keep pace with the evolving demands of healthcare.

Best Scientists Citing Laurie E. Gaspar

Trending Scientists

Recently Published Articles